Raphas Co., Ltd. Stock price

Equities

A214260

KR7214260002

Personal Products

End-of-day quote Korea S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
17,010 KRW -0.70% Intraday chart for Raphas Co., Ltd. -2.24% -11.82%
Sales 2022 23.64B 17.56M Sales 2023 27.94B 20.76M Capitalization 165B 123M
Net income 2022 -8.51B -6.32M Net income 2023 -8.8B -6.54M EV / Sales 2022 5.27 x
Net cash position 2022 9.8B 7.28M Net Debt 2023 6.89B 5.12M EV / Sales 2023 6.17 x
P/E ratio 2022
-16.1 x
P/E ratio 2023
-18.9 x
Employees 92
Yield 2022 *
-
Yield 2023
-
Free-Float 70.5%
More Fundamentals * Assessed data
Dynamic Chart
Raphas Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. CI
Raphas Co., Ltd. authorizes a Buyback Plan. CI
Raphas Co., Ltd. announced that it has received KRW 8 billion in funding CI
Raphas Co., Ltd. announced that it expects to receive KRW 8 billion in funding CI
Tranche Update on Raphas Co., Ltd.'s Equity Buyback Plan announced on January 11, 2023. CI
Tranche Update on Raphas Co., Ltd.'s Equity Buyback Plan announced on January 11, 2023. CI
Raphas Co., Ltd.'s Equity Buyback announced on January 11, 2023, has expired with 178,900 shares, representing 2.12% for KRW 3,989.27 million. CI
Raphas Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Raphas Co., Ltd. announced that it has received KRW 20 billion in funding from a group of investors CI
Raphas Co., Ltd. announced that it expects to receive KRW 20 billion in funding from a group of investors CI
Tranche Update on Raphas Co., Ltd.'s Equity Buyback Plan announced on January 11, 2023. CI
Tranche Update on Raphas Co., Ltd.'s Equity Buyback Plan announced on September 29, 2022. CI
Tranche Update on Raphas Co., Ltd.'s Equity Buyback Plan announced on September 29, 2022. CI
Raphas Co., Ltd.'s Equity Buyback announced on September 29, 2022 has expired with 161,100 shares, representing 1.87% for KRW 2,997.45 million. CI
Raphas Co., Ltd. announces an Equity Buyback for KRW 4,000 million worth of its shares. CI
More news
1 day-0.70%
1 week-2.24%
Current month+4.61%
1 month+5.78%
3 months-11.82%
6 months-30.14%
Current year-11.82%
More quotes
1 week
16 820.00
Extreme 16820
17 950.00
1 month
16 020.00
Extreme 16020
17 950.00
Current year
15 720.00
Extreme 15720
20 150.00
1 year
15 720.00
Extreme 15720
31 450.00
3 years
15 000.00
Extreme 15000
80 500.00
5 years
7 500.00
Extreme 7500
80 500.00
10 years
7 500.00
Extreme 7500
80 500.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 09-04-30
Director of Finance/CFO 48 14-04-14
Chief Tech/Sci/R&D Officer 52 -
Members of the board TitleAgeSince
Chief Executive Officer 55 09-04-30
Director of Finance/CFO 48 14-04-14
Director/Board Member 48 15-01-31
More insiders
Date Price Change Volume
24-03-28 17,010 -0.70% 18,388
24-03-27 17,130 -1.21% 39,087
24-03-26 17,340 -2.58% 32,075
24-03-25 17,800 +1.08% 41,960
24-03-22 17,610 +1.21% 32,277

End-of-day quote Korea S.E., March 27, 2024

More quotes
Raphas Co., Ltd. is a Korea-based company mainly engaged in the research, development manufacturing and distribution of microarray patches. The Company develops cosmetics based on microstructure technology. In addition, the Company sells cosmetics, pharmaceutical patches, health functional foods under the brand name of Acropass.
More about the company
  1. Stock
  2. Equities
  3. Stock Raphas Co., Ltd. - Korea S.E.